Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Pharmacology
  4. Poly(lactic-co-glycolic) acid microspheres encapsulated in Pluronic F-127 prolong Hirudin delivery and improve functional recovery from a demyelination lesion

Poly(lactic-co-glycolic) acid microspheres encapsulated in Pluronic F-127 prolong Hirudin delivery and improve functional recovery from a demyelination lesion

Biomaterials, 2014 · DOI: 10.1016/j.biomaterials.2014.06.051 · Published: October 1, 2014

PharmacologyRegenerative MedicineBiomedical

Simple Explanation

The study explores the use of biomaterials to reduce scar formation in the central nervous system after injury. It investigates whether thrombin inhibitors delivered locally can mitigate the negative effects of blood-borne proteins after spinal cord injury. The research focuses on using PLGA microspheres and Pluronic F-127 hydrogels for sustained delivery of thrombin inhibitors like heparin and hirudin.

Study Duration
Not specified
Participants
Adult mice (8 weeks)
Evidence Level
Not specified

Key Findings

  • 1
    Thrombin increases endogenous neural progenitor proliferation in the intact murine spinal cord.
  • 2
    Hirudin-loaded PLGA/F-127 gels reduce macrophage presence at the lesion site compared to control and heparin-treated animals.
  • 3
    Hirudin-loaded materials accelerate recovery in coordinated stepping and increase oligodendrocyte densities.

Research Summary

The study investigates the potential of thrombin inhibitors to improve cellular regeneration after spinal cord injury. PLGA microspheres and Pluronic F-127 hydrogels were used to create depot formulations for sustained local delivery of heparin and hirudin. Controlled delivery of hirudin accelerates functional recovery from a demyelination lesion in the spinal cord.

Practical Implications

Therapeutic Potential

Biomaterials designed for prolonged release of thrombin inhibitors hold promise for mitigating scarring and promoting regenerative therapies in the CNS.

Drug Delivery

PLGA/F-127 hydrogels can be used for controlled delivery of therapeutic peptides like hirudin to specific sites in the spinal cord.

Functional Recovery

Hirudin delivery post-injury can accelerate motor function recovery and increase oligodendrocyte populations.

Study Limitations

  • 1
    The persistence of injected material affected macrophage infiltration.
  • 2
    The population of reactive astrocytes was similar to control animals, likely due to the persistence of the PLGA/F-127 hydrogel.
  • 3
    Faster release characteristics of hirudin compared to heparin and albumin is expected due to its low molecular weight.

Your Feedback

Was this summary helpful?

Back to Pharmacology